[ATRC] AtriCure, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 19.23 Change: 0.41 (2.15%)
Ext. hours: Change: 0 (0%)

chart ATRC

Refresh chart

Strongest Trends Summary For ATRC

ATRC is in the long-term up 74% in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: AtriCure, Inc., a medical device company, provides atrial fibrillation solutions worldwide. It provides isolator bipolar radio-frequency (RF) ablation clamps that are used for ablation during open-heart procedures; and ablation and sensing unit, a compact power generator that provides the RF energy for its clamps, multifunctional pens, and coolrail linear ablation devices. The company also offers AtriCure Switch Box, a compact switch box, which offers the technology needed for the dual pulsing electrodes in isolator synergy clamps; isolator multifunctional pens that enable surgeons to evaluate cardiac arrhythmias, as well as to perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and coolrail linear ablation device, a disposable linear RF ablation device that allows physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. In addition, it provides RF ablation devices, such as COBRA Fusion Surgical Ablation System; C

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-1.06 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 12.72% Sales Growth - Q/Q1.6% P/E-20.6
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-8.97% ROE-10.71% ROI-10.69%
Current Ratio3.79 Quick Ratio3.18 Long Term Debt/Equity Debt Ratio0.19
Gross Margin70.96% Operating Margin-12.07% Net Profit Margin-12.24% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.82 M Cash From Investing Activities2.56 M Cash From Operating Activities-8.97 M Gross Profit21.73 M
Net Profit-5.27 M Operating Profit-5.14 M Total Assets153.41 M Total Current Assets93.42 M
Total Current Liabilities24.63 M Total Debt6.08 M Total Liabilities24.85 M Total Revenue29.89 M
Technical Data
High 52 week35.58 Low 52 week22.87 Last close29.42 Last change-0.98%
RSI43.69 Average true range0.72 Beta0.63 Volume87.66 K
Simple moving average 20 days0.2% Simple moving average 50 days2.98% Simple moving average 200 days-4.84%
Performance Data
Performance Week-0.64% Performance Month8.04% Performance Quart-11.36% Performance Half-3.48%
Performance Year23.04% Performance Year-to-date-3.86% Volatility daily1.46% Volatility weekly3.27%
Volatility monthly6.69% Volatility yearly23.18% Relative Volume226.41% Average Volume263.75 K
New High New Low

News

2019-11-12 08:00:00 | AtriCure to Participate at the Piper Jaffray 31st Annual Healthcare Conference

2019-11-04 17:41:12 | Edited Transcript of ATRC earnings conference call or presentation 30-Oct-19 8:30pm GMT

2019-10-30 18:15:10 | AtriCure ATRC Reports Q3 Loss, Tops Revenue Estimates

2019-10-30 16:02:00 | AtriCure Reports Third Quarter 2019 Financial Results

2019-10-27 14:02:27 | Is AtriCure Inc. ATRC A Good Stock To Buy ?

2019-10-23 10:33:02 | Analysts Estimate AtriCure ATRC to Report a Decline in Earnings: What to Look Out for

2019-10-21 08:00:00 | AtriCure to Participate in Upcoming Investor Conferences

2019-10-09 18:18:23 | This Hedge Fund Returns 22% Annually, Here Are Its Latest Picks

2019-10-08 11:06:12 | Does AtriCure's NASDAQ:ATRC Share Price Gain of 64% Match Its Business Performance?

2019-10-08 08:00:00 | AtriCure to Announce Third Quarter 2019 Financial Results

2019-09-02 15:18:57 | How AtriCure, Inc.'s NASDAQ:ATRC Earnings Growth Stacks Up Against The Industry

2019-08-28 10:50:02 | AtriCure Gains Expanded Labeling for Atriclip, Braces LAA Arm

2019-08-27 08:00:00 | AtriCure Receives Clearance for Expanded Labeling Claims for AtriClip Devices

2019-08-26 08:00:00 | AtriCure to Participate at the Morgan Stanley 17th Annual Global Healthcare Conference

2019-08-14 14:26:22 | The Funded: 6 Bay Area companies raise $274M at midweek

2019-08-13 14:16:00 | AtriCure Completes Acquisition of SentreHEART

2019-08-12 11:04:09 | AtriCure could pay up to $300M to acquire California firm

2019-08-12 05:30:00 | AtriCure Enters Into Definitive Agreement to Acquire SentreHEART

2019-07-31 14:39:55 | Edited Transcript of ATRC earnings conference call or presentation 30-Jul-19 8:30pm GMT

2019-07-31 08:24:11 | AtriCure Inc ATRC Q2 2019 Earnings Call Transcript

2019-07-30 18:35:10 | AtriCure ATRC Reports Q2 Loss, Tops Revenue Estimates

2019-07-30 16:02:00 | AtriCure Reports Second Quarter 2019 Financial Results

2019-07-30 14:30:00 | AtriCure, Inc. to Host Earnings Call

2019-07-26 14:09:00 | AtriCure NASDAQ:ATRC May Be Weighed Down By Its Debt

2019-07-23 10:32:02 | Will AtriCure ATRC Report Negative Earnings Next Week? What You Should Know

2019-07-17 16:00:00 | AtriCure to Participate at the Canaccord Genuity 39th Annual Growth Conference

2019-07-12 10:15:03 | Atricure Inc ATRC President, CEO, & Director Michael H Carrel Sold $800,000 of Shares

2019-07-10 08:00:00 | AtriCure to Announce Second Quarter 2019 Financial Results

2019-07-06 07:00:00 | Dayton's largest public company executive compensations

2019-06-14 09:09:44 | Hedge Funds Have Never Been This Bullish On AtriCure Inc. ATRC

2019-05-24 13:34:35 | Is AtriCure, Inc. NASDAQ:ATRC Worth US$29.31 Based On Its Intrinsic Value?

2019-05-05 15:53:23 | These stocks have 'underappreciated' stories, Wall Street analysts say

2019-05-02 14:58:06 | Hedge Funds Have Never Been More Bullish On AtriCure Inc. ATRC

2019-04-26 07:28:21 | AtriCure Inc ATRC Q1 2019 Earnings Call Transcript

2019-04-26 00:50:36 | Edited Transcript of ATRC earnings conference call or presentation 25-Apr-19 8:30pm GMT

2019-04-25 17:05:25 | AtriCure: 1Q Earnings Snapshot

2019-04-25 16:01:00 | AtriCure Reports First Quarter 2019 Financial Results

2019-04-25 14:30:00 | AtriCure, Inc. to Host Earnings Call

2019-04-23 08:00:00 | AtriCure Announces First Patient Enrollment in the DEEP IDE Trial Restart

2019-04-18 10:33:02 | AtriCure ATRC May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-04-04 08:00:00 | AtriCure to Announce First Quarter 2019 Financial Results

2019-04-01 10:00:00 | AtriCure to Present at the Needham & Company’s 18th Annual Healthcare Conference

2019-03-05 07:40:00 | Factors of Influence in 2019, Key Indicators and Opportunity within Expedia Group, Lumentum, Patterson Companies, Allscripts Healthcare Solutions, AtriCure, and Biohaven Pharmaceutical Holding — New Research Emphasizes Economic Growth

2019-03-02 00:48:11 | AtriCure Inc ATRC Files 10-K for the Fiscal Year Ended on December 31, 2018

2019-03-01 06:53:53 | Edited Transcript of ATRC earnings conference call or presentation 28-Feb-19 9:30pm GMT

2019-02-28 21:50:31 | AtriCure Inc ATRC Q4 2018 Earnings Conference Call Transcript

2019-02-28 16:02:00 | AtriCure Reports Fourth Quarter and Full Year 2018 Financial Results

2019-02-25 20:38:41 | Mason firm to add 100-plus jobs in $15M expansion

2019-02-21 10:31:03 | Analysts Estimate AtriCure ATRC to Report a Decline in Earnings: What to Look Out for

2019-02-19 08:00:00 | AtriCure Announces The Society of Thoracic Surgeons Has Endorsed the Company’s Advanced Ablation Courses in the United States